What is the official ID of this bill?
The official print number for this legislation is S 5021.
Ensuring Patient Access to Discounted 340B Drugs via Contract Pharmacies
This bill clarifies the 340B drug discount program, ensuring that covered entities can purchase discounted drugs regardless of whether they are dispensed directly or through contract pharmacies. This protects patient access to essential, often specialty, medications and ensures healthcare providers can use the savings to support patient care. Drug manufacturers are prohibited from imposing restrictive conditions on these purchases, such as limits on delivery or data submission requirements.
Key points
Drug manufacturers must provide 340B discounts whether the drug is dispensed by the facility's own pharmacy or a contract pharmacy.
New civil monetary penalties (up to $2 million per day) are established for manufacturers who knowingly and intentionally violate the requirements.
The law aims to ensure access to vital specialty drugs, which often rely on contract pharmacy arrangements for distribution.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.